Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow-to-Debt Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A cash flow-to-debt ratio. Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Cash Flow-to-Debt Ratio of 0.55x as of December 2024, meaning its operating cash flow of CN¥126.49 Million could theoretically repay 1% of its total liabilities (CN¥228.88 Million) in one year. Check cash flow quality index of Jiangsu Canopus Wisdom Medical Technolog to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Cash flow-to-debt ratio of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. Historical debt coverage capacity for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A across 5 annual periods. Check total reinvestment intensity of Jiangsu Canopus Wisdom Medical Technolog to assess the company's total reinvestment commitment from operating cash flow.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2020–2024)
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Canopus Wisdom Medical Technolog.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | CN¥126.49 Million | CN¥228.88 Million | ▼ -50.1% |
| 2023 | 1.11x | CN¥163.13 Million | CN¥147.37 Million | ▲ +110.6% |
| 2022 | 0.53x | CN¥94.63 Million | CN¥180.04 Million | ▼ -52.7% |
| 2021 | 1.11x | CN¥163.45 Million | CN¥146.95 Million | ▲ +52.9% |
| 2020 | 0.73x | CN¥114.07 Million | CN¥156.79 Million | — |